51,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
  • Broschiertes Buch

Preterm labour is the leading cause of perinatal morbidity and mortality in current obstetric practice and there is currently no satisfactory therapeutic intervention available for this problem. Although much research has been undertaken, the factors involved in regulation of uterine contractility, in addition to events leading to the initiation of human labour, are only partly understood. Myometrial contractility is influenced by a variety of physiological mechanisms including: intracellular signalling, calcium, cell membrane receptors and hormones. The studies presented here investigate the…mehr

Produktbeschreibung
Preterm labour is the leading cause of perinatal morbidity and mortality in current obstetric practice and there is currently no satisfactory therapeutic intervention available for this problem. Although much research has been undertaken, the factors involved in regulation of uterine contractility, in addition to events leading to the initiation of human labour, are only partly understood. Myometrial contractility is influenced by a variety of physiological mechanisms including: intracellular signalling, calcium, cell membrane receptors and hormones. The studies presented here investigate the molecular and pharmacological mechanisms of uterine contractility including genes involved in calcium sensitisation, the prostaglandins and pharmacological inhibitors specific to both.
Autorenporträt
Anne M. Friel, Ph.D Biomedical Science, National University of Ireland ; BSc Applied Biopharmaceutical & Healthcare Sciences, Galway Mayo-Institute of Technology ; BSc Analytical Science, Dublin City University. Scientifique senior spécialisé dans la médecine translationnelle et la biopharmaceutique.